@FierceBiotech: Special report: The Alzheimer's pipeline... What's next? Report | Follow @FierceBiotech
@JohnCFierce: Resverlogix touts positive PhIIb atherosclerosis data, sets sights on PhIII deal. More | Follow @JohnCFierce
@RyanMFierce: What changes will Roche vet Pascal Soriot make as CEO of AstraZeneca? More | Follow @RyanMFierce
> The European Commission has approved Novartis' ($NVS) Jakavi, a new drug for myelofibrosis licensed from Incyte. Story
> LPath reported that the FDA has lifted the clinical hold on iSONEP, an anti-S1P monoclonal antibody being developed as a potential treatment for wet AMD and possibly other ocular disorders. Release
> Catalyst Pharmaceutical Partners is raising $6 million in a new stock offering designed to fund its drug development work. Story
> Rexahn Pharmaceuticals says it gathered positive data in a Phase II clinical study of Archexin, its clinical-stage pancreatic cancer drug candidate. A penny stock company, Rexahn's shares jumped 22% on the news. Release
Pharma News
@FiercePharma: AstraZeneca's gain is Roche's loss: Stock down 1% after $AZN woos away Pascal Soriot for CEO job. More | Follow @FiercePharma
> Forest adopts 'poison pill' to fend off Icahn. Report
> AstraZeneca entices Roche exec to take on CEO challenge. News
> Gilead draws early fire for new HIV med's $28K price. Story
@FierceMedDev: Moving on from the Duet recall, Covidien gets a 510(k) for its next-gen surgical stapler. News | Follow @FierceMedDev
@MarkHFierce: Stent use can help certain patients more than medical therapy if used on the early side. Release | Follow @MarkHFierce
@DamianFierce: Joining other big shots in the device game, Medtronic has opened an R&D center in China. Report | Follow @DamianFierce
> Shake-up at Roche puts Diggelmann in charge of diagnostics. News
Biotech Research News
> Acorda's drug treats nerve damage-related ED in preclinical test. Article
> Novira raises $23M for hepatitis B/HIV drug work. News
> Genentech, U. Minnesota scientists discover new colon cancer red flags. Story
> Johns Hopkins team turning blood cells into stem cells. More
> Melanoma stem cells may carry provocative drug target. Item
Pharma Manufacturing News
> Drugmaker EirGen thinks plan to put waste station nearby stinks. More
> Sun says FDA clears plants where Marshalls seized products in 2009. News
> CSL, whose vaccine was tied to convulsions, gets FDA closeout letter. Story
> Hospira commits to 200 jobs, $85M investment, at troubled plant. Report
And Finally… Researchers from the University of Bonn and MPI Martinsried say they have "decoded signals that boost the burning of fat." Release